The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening its clinical offerings.

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP). While the relationship between ...

Ghosh is at the helm of the HUMANOID™ Center for Excellence at the University of California San Diego, which is pioneering ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to ...

The federal government has intensified its fight against cancer with a critical aspect of prevention, with the training of ...

The sodium channel blocker market is expanding due to the increasing prevalence of neuropathic pain and the demand for more selective treatments like Nav1.7 and Nav1.8 inhibitors. Advances in drug ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual ...

Belgium is scaling its regulatory and clinical systems for Advanced Therapy Medicinal Products (ATMPs) - academia's role will ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Bildnachweis: HTGF, VentureCapital Magazin, HTGF. Life sciences expert Dr Achim Plum has been on the management team of ...